In terms of confidentiality, we have in the past proposed a separation between business-confidential information and test data. What is happening with the new substances notification program is that there is just not enough transparency for us to be able to say whether they're doing a good job or making precautionary decisions and that test data needs to be public.
On December 11th, 2006. See this statement in context.